Alzheimer's Oral Medication Study: A phase II study of an oral medication developed to block the receptor for advanced glycation end products which damage nerve cells in the brain

Alzheimer's Vaccine Study: A first-in-human, phase I study of the safety of an intramuscular vaccine against beta-amyloid in persons with mild-to-moderate Alzheimer's disease

Blood Markers, Inflammation and Oxidative Stress Study: A six-month, double-blind, placebo-controlled, single-site study of Cerefolin NAC on blood homocysteine, oxidative stress, and beta-amyloid biomarkers that may potentiate inflammation and neuronal damage

Home and Community Services Alzheimer's Study: Study of Home and Community Services in Alzheimer's Disease

Home-Based Assessment Methods for Alzheimer's Disease: Multicenter trial to evaluate home-based assessment methods for Alzheimer's disease prevention research in people over 75 years old (ADC-030-HBA)

Mild Alzheimer's Study: Daytime sleepiness and parkinsonism in patients with mild Alzheimer's disease

Mild to Severe Alzheimer's While Residing in an Assisted Living Facility: A 12-week, open-label study of the safety and efficacy of donepezil hydrochloride in subjects with mild to severe Alzheimer's disease residing in an assisted living facility

Telephone Resources and Assistance for Caregivers Study: Telephone Resources and Assistance for Caregivers (TRAC)